Integra Lifesciences Sees Q3 Adj EPS $0.53-$0.61 vs $0.56 Est; Sees Sales $410.000M-$425.000M vs $418.100M Est

Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets

U.S. stock markets rallied on October 2, 2026, following weaker-than-expected September employment data showing only 29,000 jobs added and unemployment rising to 4.2%. The soft labor report reduced expectations for a Federal Reserve rate hike this month from 64% to 21%, boosting investor sentiment particularly in tech and growth stocks. The Nasdaq Composite hit a record high, while the S&P 500 and Dow Jones also gained.

Crude Oil Down Over 1%; US Factory Orders Edge Higher In August

U.S. stocks rose Friday, led by Nasdaq (+1.27%), despite weak jobs data. Factory orders edged up; oil and gold fell. Alpha Modus surged 213%.

Integra LifeSciences shares are trading lower after the company announced it anticipates that flooding will disrupt Q3 revenue. The company narrowed its FY26 adjusted EPS guidance and cut its FY26 revenue.

8-K filing — INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Filed: 2026-10-02 AccNo: 0000917520-26-000067 Size: 194 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits